| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | -0.0035 | 0.9 |
| mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | 0.0027 | 0.9 |
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | 0.003 | 0.9 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | -0.003 | 0.9 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.0027 | 0.9 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | 0.0026 | 0.9 |
| mRNA | VER-155008 | CTRPv2 | pan-cancer | AAC | 0.0024 | 0.9 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | 0.0022 | 0.9 |
| mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | -0.0035 | 1 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | -0.0024 | 1 |